Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose

被引:42
作者
Waring, W. Stephen [1 ]
Stephen, Alexandra F. [1 ]
Malkowska, Aleksandra M. [1 ]
Robinson, Oliver D. G. [1 ]
机构
[1] Royal Infirm, Scottish Poisons Informat Bur, Edinburgh, Midlothian, Scotland
关键词
acetaminophen; alcohol; ethanol; hepatic injury; poisoning;
D O I
10.1111/j.1553-2712.2007.00019.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Little is known about the clinical significance of acute ethanol coingestion around the time of acetaminophen (paracetamol) overdose. This study prospectively examined the effect of acute ethanol coingestion on risk of hepatotoxicity among patients admitted to hospital for N-acetylcysteine (NAC) therapy after deliberate acetaminophen overdose. Methods: This was a prospective observational study and included sequential patients who presented within 24 hours of acute acetaminophen ingestion and required NAC therapy. Significant hepatotoxicity was defined by alanine transaminase > 1,000 U/L or the international normalized ratio > 1.3 after a standardized intravenous administration of 300 mg/kg NAC. Results: There were 362 patients, including 178 (49.2%) who coingested ethanol acutely. The prevalence of hepatotoxicity was 5.1% (95% CI = 2.6% to 9.5%) in those who ingested ethanol, compared to 15.2% (95% CI = 10.7% to 21.2%) in those who did not (p = 0.0027 by chi-square proportional test). Acute ethanol intake conferred a lower risk of hepatotoxicity in patients who had acetaminophen concentrations above or below the "200-line" and was independent of the interval between ingestion and assessment. Conclusions: Acute ethanol intake is associated with a lower risk of hepatotoxicity after acetaminophen overdose. This apparent protective effect cannot be explained solely by lower exposure to acetaminophen in this group, nor differences in the interval between ingestion and initiation of treatment. Further work is required to establish mechanisms by which ethanol might confer protection against hepatotoxicity, so as to identify novel strategies for reducing risk after acute acetaminophen ingestion.
引用
收藏
页码:54 / 58
页数:5
相关论文
共 26 条
  • [1] THE EFFECT OF CHRONIC ALCOHOL INTAKE ON PROGNOSIS AND OUTCOME IN PARACETAMOL OVERDOSE
    BRAY, GP
    MOWAT, C
    MUIR, DF
    TREDGER, JM
    WILLIAMS, R
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1991, 10 (06): : 435 - 438
  • [2] Interventions for paracetamol (acetaminophen) overdose
    Brok, J.
    Buckley, N.
    Gluud, C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02):
  • [3] Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism? A case for
    Buckley, NA
    Srinivasan, J
    [J]. DRUG SAFETY, 2002, 25 (09) : 619 - 624
  • [4] Buckley Nick, 2005, Clin Evid, P1738
  • [5] Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism? A case against
    Dargan, PI
    Jones, AL
    [J]. DRUG SAFETY, 2002, 25 (09) : 625 - 632
  • [6] Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies
    Hoegberg, LCG
    Angelo, HR
    Christophersen, AB
    Christensen, HR
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2002, 40 (01): : 59 - 67
  • [7] Protective effect of ethanol against acetaminophen-induced hepatotoxicity in mice -: Role of NADH:quinone reductase
    Lee, SM
    Cho, TS
    Kim, DJ
    Cha, YN
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (10) : 1547 - 1555
  • [8] Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose
    Makin, A
    Williams, R
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (06) : 341 - 349
  • [9] POTENTIATION OF ACETAMINOPHEN HEPATOTOXICITY BY ALCOHOL
    MCCLAIN, CJ
    KROMHOUT, JP
    PETERSON, FJ
    HOLTZMAN, JL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (03): : 251 - 253
  • [10] Paracetamol, alcohol and the liver
    Prescott, LF
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (04) : 291 - 301